MBF-362

· Medibiofarma S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBF-362, covering 2025-03-03 to 2025-03-03. Get the full timeline:

Most recent: Clinical Trial Update: First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors [Phase 1]